W, L., X, Z., Q, L., Y, S., & X, J. (2026). Preclinical evaluation of the antibody fragment targeting fibronectin EDB in the theranostics of radioactive iodine-resistant thyroid cancer. Bioorganic chemistry, 178, 109980. https://doi.org/10.1016/j.bioorg.2026.109980
Παραπομπή σε μορφή Chicago (17η εκδ.)W, Luo, Zhang X, Liu Q, Shi Y, και Jiang X. "Preclinical Evaluation of the Antibody Fragment Targeting Fibronectin EDB in the Theranostics of Radioactive Iodine-resistant Thyroid Cancer." Bioorganic Chemistry 178 (2026): 109980. https://doi.org/10.1016/j.bioorg.2026.109980.
Παραπομπή σε μορφή MLA (9th εκδ.)W, Luo, et al. "Preclinical Evaluation of the Antibody Fragment Targeting Fibronectin EDB in the Theranostics of Radioactive Iodine-resistant Thyroid Cancer." Bioorganic Chemistry, vol. 178, 2026, p. 109980, https://doi.org/10.1016/j.bioorg.2026.109980.